Updates
SAMHSA Guidance On 42 CFR Part 2 Revised Rule
In light of recent revisions of 42 CFR Part 2, the Substance Abuse and Mental Health Services Administration (SAMHSA) has issued several guidance documents, including a new fact sheet that includes implementation guidance. The 42 CFR Part 2 regulations serve to...
AMA Opioid Task Force Releases Drug Overdose Report
A new American Medical Association (AMA) report focuses on the increase in drug overdose deaths, investigates causes and calls for meaningful action to remove barriers to evidence-based practice in treatment, harm reduction and pain management. “It is past time for...
“Collision of Epidemics”: Coronavirus Pandemic Worsening Opioid Overdose Crisis
Since the beginning of the coronavirus pandemic, experts feared that the opioid crisis would get worse and preliminary data shows those fears are justified. Recent research shows that accessing addiction treatment is also becoming more difficult for Americans. Now,...
Experts Reach Consensus on Treatment of Adolescents with ADHD, SUD
Childhood attention-deficit/hyperactivity disorder (ADHD) is a risk factor for substance misuse and substance use disorder (SUD) in adolescence and (early) adulthood. A multidisciplinary group of dozens of experts from 17 countries reached a high level of consensus on...
Study: Expanded Access to Treatment in Prisons & Jails Can Greatly Reduce Opioid Overdose Deaths
In a new study published in the International Journal of Drug Policy on July 22, researchers from the Brown University School of Public Health found that expanding access to all three Medications for Opioid Use Disorder (MOUD) in prisons and jails can reduce overdose...
How COVID-19 Is Driving Risks in the Illicit Benzodiazepines Market
According to research conducted by Express Scripts and cited by Harvard Medical School, prescriptions for medications to treat depression, anxiety or insomnia increased by 21 percent at the beginning of the COVID-19 pandemic in February. Prescriptions of anti-anxiety...
This program will educate controlled substance prescribers on different aspects associated with pain management, including effective utilization of controlled substances to manage pain as well as identifying signs of patient abuse or misuse of these medication. Completing this activity will fulfill 1.5 hours of the controlled substance CME/CPD requirement for the providers who prescribe controlled substances in NC.
These trainings are provided by by Area LAHEC in partnership with Community Impact of North Carolina and supported by the NC Department of Health and Human Services, Division of Mental Health, Developmental Disabilities and Substance Abuse Services, with funding from the Substance Abuse and Mental Health Services Administration, State Opioid Response Supplemental – Prevention Funds.
Learn more about our conferences and educational opportunities
Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.